ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 84 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,097,127 | +5.3% | 1,129,623 | +4.7% | 0.00% | – |
| Q1 2024 | $15,288,126 | -4.9% | 1,078,908 | +1.3% | 0.00% | – |
| Q4 2023 | $16,073,355 | -0.3% | 1,065,166 | +4.4% | 0.00% | – |
| Q3 2023 | $16,121,009 | +5.5% | 1,020,317 | +1.0% | 0.00% | – |
| Q2 2023 | $15,287,599 | +13.5% | 1,009,749 | +8.7% | 0.00% | – |
| Q1 2023 | $13,465,642 | +8.2% | 928,665 | +0.9% | 0.00% | – |
| Q4 2022 | $12,441,821 | -9.3% | 920,253 | +5.8% | 0.00% | – |
| Q3 2022 | $13,714,000 | +47.7% | 870,147 | +14.1% | 0.00% | – |
| Q2 2022 | $9,285,000 | +129.8% | 762,364 | +77.1% | 0.00% | – |
| Q1 2022 | $4,041,000 | -44.4% | 430,404 | +1.3% | 0.00% | – |
| Q4 2021 | $7,274,000 | – | 424,952 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $63,067,422 | 34.64% |
| 5AM Venture Management, LLC | 4,408,379 | $62,819,401 | 14.05% |
| StepStone Group LP | 761,277 | $10,848,197 | 2.20% |
| Baker Brothers Advisors | 4,865,819 | $69,337,921 | 0.89% |
| TCG Crossover Management, LLC | 584,955 | $8,335,609 | 0.87% |
| Nan Fung Group Holdings Ltd | 49,082 | $699,419 | 0.75% |
| Redmile Group, LLC | 560,971 | $7,993,837 | 0.48% |
| Corton Capital Inc. | 54,973 | $783,365 | 0.41% |
| CORNERCAP INVESTMENT COUNSEL INC | 13,014 | $185,450 | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,496,250 | 0.03% |